Consensus $11.08. Raises FY24 revenue view to $15.43B-$15.53B from $15.33B-$15.58B, consensus $15.46B. Narrows FY24 adjusted EBITDA view to $3.71B-$3.77B from $3.7B-$3.8B. The company said, “The company updated its full-year 2024 guidance for revenue to be between $15,425 million and $15,525 million, Adjusted EBITDA between $3,705 million and $3,765 million, and Adjusted Diluted Earnings per Share between $11.10 and $11.30.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IQV:
- IQV Earnings this Week: How Will it Perform?
- Iqvia price target lowered to $235 from $241 at Baird
- Iqvia price target lowered to $255 from $275 at Barclays
- ‘The CRO Sector Looks Appealing,’ Says Goldman Sachs — Here Are 2 Stocks to Consider
- Dollar Tree downgraded, Lululemon upgraded: Wall Street’s top analyst calls